Tags : Pregabalin

Pfizer Reports Results of Lyrica (pregabalin) in P-III Study for

Tuba Khan May 27, 2019

Shots: The P-III study involves assessing of Lyrica (pregabalin, bid, 5mg/10mg) vs PBO in 219 patients in a ratio (1:1:1) with PGTC seizures aged 5 to 65 yrs. across 21 […]readmore

Tags : Pregabalin

Pfizer Reports Results of Lyrica (pregabalin) in P-III Study for

Latest Posts

PharmaShots Weekly Snapshots (November 15 – 19, 2021)

Jazz’ Sunosi (solriamfetol) Receives NICE Recommendation for the Treatment of Excessive Daytime Sleepiness Caused by Narcolepsy

Antengene’s Selinexor (ATG-010) Receives NMPA’s IND Approval for P-I/II SWATCH Study to Treat Non-Hodgkin Lymphoma

Daiichi Sankyo Reports Results of Quizartinib in P-III QuANTUM-First Trial for the Treatment of FLT3-ITD Positive AML

Company

Tags : Pregabalin

﻿Pfizer Reports Results of Lyrica (pregabalin) in P-III Study for

Latest Posts

PharmaShots Weekly Snapshots (November 15 – 19, 2021)

Jazz’ Sunosi (solriamfetol) Receives NICE Recommendation for the Treatment of Excessive Daytime Sleepiness Caused by Narcolepsy

Antengene’s Selinexor (ATG-010) Receives NMPA’s IND Approval for P-I/II SWATCH Study to Treat Non-Hodgkin Lymphoma

Daiichi Sankyo Reports Results of Quizartinib in P-III QuANTUM-First Trial for the Treatment of FLT3-ITD Positive AML

Categories

Related Topics

Company

Pfizer Reports Results of Lyrica (pregabalin) in P-III Study for